Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC5A2 | P31639 | 6/20 | 0.57 |
| ▸ | SLC28A3 | Q9HAS3 | 2/20 | 0.56 |
| ▸ | SLC5A1 | P13866 | 2/20 | 0.55 |
| ▸ | ATM | Q13315 | 1/20 | 0.54 |
| ▸ | TYR | P14679 | 2/20 | 0.52 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.52 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Helicin SCHEMBL9844557 | 1.00 | SLC5A2 (0.57) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| Helicin SCHEMBL20723406 | 1.00 | SLC5A2 (0.57) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| Helicin SCHEMBL987304 | 1.00 | SLC5A2 (0.57) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| Helicin SCHEMBL9844555 | 1.00 | SLC5A2 (0.57) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| Helicin SCHEMBL988045 | 1.00 | SLC5A2 (0.57) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| Helicin SCHEMBL9888348 | 1.00 | SLC5A2 (0.57) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| SCHEMBL31064785 | 0.99 | SLC28A3 (0.55) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| Helicin SCHEMBL18864319 | 0.93 | SLC5A2 (0.54) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| SCHEMBL14120353 | 0.86 | HIF1A (0.54) | SLC5A2SLC28A3SLC5A1ATMTYR | |
| SCHEMBL16874167 | 0.86 | ATM (0.54) | SLC5A2SLC28A3SLC5A1ATMTYR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 213 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025095174-A1 | DEEP-FRIED AND BRAISED CHICKEN SAUCE WITH IMPROVED COLOR AND TEXTURE AND DEEP-FRIED AND BRAISED CHICKEN PREPARED BY USING SAME | 지병욱 | 2025-05-08 | — | — | WO | claimed |
| US-12285488-B2 | Oral dosage form containing theobromine-free cocoa | LTS LOHMANN THERAPIE-SYSTEME AG (DE) | 2025-04-29 | — | — | US | claimed |
| WO-2025073376-A1 | MASKING PREPARATIONS AND COMPOUNDS FROM DAEMONOROPS DRACO (DRAGON BLOOD) | SYMRISE AG (DE) | 2025-04-10 | — | — | WO | claimed |
| US-20110177085-A1 | Bitter Taste Receptors | DEUTSCHES INSTITUT FUER ERNAEHRUNGSFORSCHUNG, STIFTUNG DES OEFFENTLICHEN RECHTS, VERTRETEN DURCH DEN STIFTUNGSVORSTAND (DE) | 2011-07-21 | — | — | US | claimed |
| EP-2270157-A2 | Bitter taste receptors | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DE) | 2011-01-05 | — | — | EP | claimed |
| EP-2163623-A2 | Bitter taste receptors | Deutsches Institut für Ernährungsforschung Potsdam-Rehbrücke (DE) | 2010-03-17 | — | — | EP | claimed |
| EP-1337229-B1 | IMMOBILISATION OF ACTIVE AGENTS ON FIBRES | HENKEL AG & CO KGAA (DE) | 2009-09-30 | — | — | EP | claimed |
| US-20060248602-A1 | Bitter taste receptors | DEUTSCHES INSTITUT FUR ERNAHRUNGSFORSCHUNG (DE) | 2006-11-02 | — | — | US | claimed |
| EP-1543122-A2 | BITTER TASTE RECEPTORS | Deutsches Institut für Ernährungsforschung (DE) | 2005-06-22 | — | — | EP | claimed |
| WO-2004029087-A2 | BITTER TASTE RECEPTORS | Deutsches Institut für Ernährungsforschung (DE) | 2004-04-08 | — | — | WO | claimed |
| EP-0992277-B1 | Dry semipermeable reverse osmosis membrane and process for preparing the same using saccharides | SAEHAN IND INC (KR) | 2004-04-07 | — | — | EP | claimed |
| EP-1337229-A2 | IMMOBILISATION OF ACTIVE AGENTS ON FIBRES | Henkel Kommanditgesellschaft auf Aktien (DE) | 2003-08-27 | — | — | EP | claimed |
| WO-2002043675-A2 | IMMOBILISATION OF ACTIVE AGENTS ON FIBRES | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2002-06-06 | — | — | WO | claimed |
| EP-0992277-A1 | Dry semipermeable reverse osmosis membrane and process for preparing the same using saccharides | SAEHAN INDUSTRIES, INC. (KR) | 2000-04-12 | — | — | EP | claimed |
| US-4255319-A | PHOSPHINE INHIBITION; NONTOXIC; STORAGE STABILITY; MATERIALS HANDLING | UNION CARBIDE CORPORATION (US) | 1981-03-10 | — | — | US | claimed |
| JP-9168385-A | — | — | None | — | — | JP | disclosed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| US-4999429-A | Process for the preparation of α,α,β-1-trifluoro-1-olefinic derivatives | ETHYL CORPORATION (US) | 1991-03-12 | — | — | US | disclosed |
| US-4837327-A | Process for nucleophilic fluoroalkylation of aldehydes | ETHYL CORPORATION (US) | 1989-06-06 | — | — | US | disclosed |
| US-4255319-A | PHOSPHINE INHIBITION; NONTOXIC; STORAGE STABILITY; MATERIALS HANDLING | UNION CARBIDE CORPORATION (US) | 1981-03-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110177085-A1 | Bitter Taste Receptors | TAS2R30, TAS2R50, TAS2R10 | SLC5A2 858/4885SLC28A3 1399/4885SLC5A1 753/4885 |
| US-20060248602-A1 | Bitter taste receptors | TAS2R1, TAS2R30, TAS2R5 | SLC5A2 964/4885SLC28A3 1555/4885SLC5A1 769/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | SLC5A2 213/4885SLC28A3 2008/4885SLC5A1 864/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.